Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 87 pages
Exam (elaborations)

NORTH CAROLINA MPJE – PARISH VERSION | COMPREHENSIVE PHARMACY LAW EXAM PREP, PRACTICE QUESTIONS, CORRECT ANSWERS AND STUDY GUIDE

Document preview thumbnail
Preview 4 out of 87 pages

Prepare for the North Carolina MPJE – Parish Version with this comprehensive pharmacy law exam prep and study guide designed to help candidates review essential federal and North Carolina pharmacy laws and regulations. This resource includes practice questions and correct answers covering pharmacy practice standards, pharmacist and pharmacy technician responsibilities, controlled substances, prescription requirements, dispensing regulations, recordkeeping, drug distribution, licensing, professional conduct, patient safety, North Carolina Board of Pharmacy regulations, and other important topics relevant to MPJE preparation. Ideal for candidates preparing for the North Carolina Multistate Pharmacy Jurisprudence Examination, this guide helps reinforce key legal concepts, improve knowledge retention, identify areas requiring additional review, and build confidence before the examination.

Content preview

NORTH CAROLINA MPJE – PARISH VERSION
| COMPREHENSIVE PHARMACY LAW EXAM
PREP, PRACTICE QUESTIONS, CORRECT
ANSWERS AND STUDY GUIDE
| GRADED A+ | GUARANTEED SUCCESS


Updated 2026 Questions and Answers

100% Verified Exam Prep

,breakthrough therapy Give the FDA classification for the following description:
Drugs that provide substantial improvement over current tx


0 (zero) The max number of refills on an isotretinoin prescription


FALSE (it would have to be 503b) TRUE or FALSE: A 503a pharmacy can compound medications only for another 503a
pharmacy


priority review Give the FDA classification for the following description:
The FDA's goal is to take action on the application within 6 month


Prior Approval Supplement A drug manufacturer wants to change the way a drug that is currently on the market is
manufactured/produced. What application would be submitted to the FDA?


PIECE of LEGISLATION: Pure Food and Drug Act of 1906
prohibited the adulteration and misbranding of foods and
drugs in interstate commerce


PIECE of LEGISLATION: Food, Drug, and Cosmetic Act of 1938
Core of today's drug laws. No new drug can be
marketed/sold until proven safe and approved by FDA. Labels
must contain adequate directions for use and warnings about
their habit-forming properties


PIECE of LEGISLATION: Durham-Humphrey Amendment of 1951
Established two classes of medications: Rx and OTC.
Authorized oral prescriptions and refills of prescription drugs.
Introduced label requirements for pharmacies


PIECE of LEGISLATION: Kefauver-Harris Amendment of 1962
Drugs must also be proven effective (in addition to safe).
Transferred prescription drug advertising from Federal Trade
Commission (FTC) to FDA. Established Good Manufacturing
Practices. Required informed consent of research participants
and reporting of ADRs


PIECE of LEGISLATION: Federal Comprehensive Drug Abuse Prevention and Control Act of 1970
AKA Controlled substances act.

,PIECE of LEGISLATION: Medical Device Amendments of 1976
Established criteria for classifying devices into one of three
classes


PIECE of LEGISLATION: Orphan Drug Act of 1983
Provides tax and licensing initiatives for manufacturers who
develop drugs or biologicals for rare diseases or conditions


PIECE of LEGISLATION: Drug Price Competition (DPC) and Patent Term Restoration Act (PTRA) of 1984
Also known as the Waxman-Hatch Amendment. Streamlined
the generic drug approval process while giving patent
extensions for innovative drugs


PIECE of LEGISLATION: Prescription Drug Marketing Act (PDMA) of 1987
Bans sale, trade, or purchase of Rx drug samples. Established
sales restrictions and recordkeeping requirements for Rx drug
samples. Prohibits hospitals and other health care entities from
reselling their Rx drugs to other businesses. Requires state
licensing of wholesalers. Bans re-importation of Rx drugs
except by manufacturer


PIECE of LEGISLATION: The Omnibus Budget Reconciliation Act of 1990
AKA OBRA-90. Included prospective drug use review, patient
counseling, patient profiles


PIECE of LEGISLATION: Prescription Drug User Fee Act of 1992
Drug manufacturers required to pay fees when submitting a
new drug application


PIECE of LEGISLATION: Dietary Supplement Health & Education Act (DSHEA) of 1994
Created a new category of food called "dietary supplements".
Permits manufacturers to make claims that would have
otherwise been illegal under FDCA. Forced FDA to regulate
dietary supplements more as foods than drugs

, PIECE of LEGISLATION: Health Insurance Portability and Accountability Act of 1996 (HIPAA)
Regulated the privacy and security of health information;
improved efficiency and effectiveness of the health care
system; improved the continuity of health insurance coverage
and prohibits discrimination in health coverage


PIECE of LEGISLATION: Food & Drug Administration Modernization Act (FDAMA) of 1997
Streamlined regulatory procedures to expedite the availability
of safe and effective drugs and devices; expands FDA
authority over OTC drugs; establishes a data bank of
information on clinical trials


PIECE of LEGISLATION: Drug Addiction Treatment Act (DATA) of 2000
Piece of legislation that established that allows office-based
opioid addiction treatment (i.e. Suboxone)


PIECE of LEGISLATION: Anabolic Steroids Act of 2004
Established that all anabolic steroids are Schedule III


Pseudoephedrine laws (Give 2) Combat Methamphetamine Epidemic Act of 2005, Methamphetamine Prevention Act of
2008


PIECE of LEGISLATION: The Patient Safety and Quality Improvement Act of 205 (PSQIA)
established that creates a voluntary program through which
health care providers, including pharmacies, share information
related to patient safety events with patient safety
organizations


PIECE of LEGISLATION: Food & Drug Administration Amendments Act (FDAAA) of 2007
FDA may mandate labeling changes related to safety; require
clinical trial data reporting and registries; require post-market
clinical studies to assess risk (Phase 4 studies)


PIECE of LEGISLATION: Biologics Price Competition and Innovation Act (included in the Affordable Care Act of
Allows a pathway for biosimilar approval 2010)

Document information

Uploaded on
August 18, 2026
Number of pages
87
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
CA$15.70

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
DrExamVault
5.0
(1)
Sold
38
Followers
0
Items
3003
Last sold
5 hours ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions